Edison Investment Research publishes Executive Interview with Rahul Agrawal, CMO and Head of R&D; and Björn Dahlöf, CSO, Cereno Scientific

On Monday morning, Edison released a video interview, where Soo Romanoff, healthcare managing director of Edison Group, interviews Rahul Agrawal, CMO, and Björn Dahlöf, CSO, discussing the Cereno Scientifics innovative product portfolio and targeting unmet needs in the cardiovascular diseases (CVD) space.

The interview is available on Edison’s website. See the full interview here.